Clinical Research Directory
Browse clinical research sites, groups, and studies.
Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
Sponsor: Chong Kun Dang Pharmaceutical
Summary
The purpose of this study is to prove that the temporary symptom improvement effect on knee osteoarthritis using CKD-981
Official title: A Randomized, Double-blind, Sham-controlled, Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 in Patients With Degenerative Knee Osteoarthritis
Key Details
Gender
All
Age Range
40 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-05-12
Completion Date
2025-11
Last Updated
2025-05-14
Healthy Volunteers
No
Conditions
Interventions
CKD-981(1)
20 minutes per day, 5 days a week for 6 weeks.
CKD-981(2)
20 minutes per day, 5 days a week for 6 weeks.
Sham device
20 minutes per day, 5 days a week for 6 weeks.
Reference Drug
QD for 6 weeks
Placebo Drug
QD for 6 weeks
Locations (1)
Wonju Severance Christian Hospital
Wŏnju, South Korea